1. Evsikov AV, de Vries WN, Peaston A, Fancher K, Chen F,
Radford E, Latham K, Blake J, Bult C, Solter D, Knowles BB. 2004. Systems
biology of the 2-cell embryo. Cytogenet. Genome. Res., 105:240-250.
2. Solter, D., Hiiragi, T., Evsikov, A.V., Moyer, J., de
Vries, W.N., Peaston, A.E., and Knowles, B.B. 2004. Epigenetic mechanisms in
early mammalian development. Cold Spring Harbor Symposia on Quantitative
Biology 69: 11-17.
3.Hiiragi, T. and Solter, D. 2004. First cleavage plane of
the mouse egg is not predetermined but defined by the topology of the two
apposing nuclei. Nature 430: 360-364.
4. Chen W, Masterman K-A, Basta S, Dimopoulos N, Knowles BB,
Bennink, JR and Jonathan W. Yewdell.2004. Cross-Priming of CD8 + T Cells to
Viral and Tumor Antigens is a Robust Phenomenon Europ.J. Immunol, 34:194-9.
5. de Vries WN, Evsikov AV, Fancher K, Haac BE, Solter D,
Kemler R, Knowles BB. 2004. Development of mouse preimplantation embryos
lacking maternal β-catenin and E-cadherin: insights into zygotic genome
activation. Development,131: 4435-45.
6. Peaston AE, Evsikov AV, Graber J, de Vries WN, Solter D,
and Knowles BB. 2004. Retrotransposons regulate host genes in mouse oocytes and
preimplantation embryos. Developmental Cell, 7: 597-606.
7. Kemler, R, Hierholzer A, Kanzler B, Kuppig S, Hansen K,
Taketo M, de Vries WN, Knowles BB, and Solter, D. 2004. Stabilization of β-catenin
in the mouse zygote leads to premature epithelial-mesenchymal transition in the
epiblast. Development,131:4435-45.
8. Mikaelian I, Blades N, Churchill GC, Fancher K, Knowles
BB, Eppig JT, Sundberg JP. 2004. Classification of spontaneous and transgenic
mammary neoplasms, Breast Cancer Res. 6:668-79.
9. Mehlmann,LM, Saeki Y, Tanaka S,. Brennan TJ, Evsikov AV,
Pendola F, Knowles BB, EppigJJ, Jaffe LA. 2004. The Gs-linked receptor GPR3
maintains meiotic arrest in mammalian oocytes Science, 306:1947-50.
10. Kemler, R, Hierholzer A, Kanzler B, Kuppig S, Hansen K,
Taketo M, de Vries WN, Knowles BB, and Solter, D. 2004. Stabilization of
b-catenin in the mouse zygote leads to premature epithelial-mesenchymal
transition in the epiblast. Development131:5817-24.
11. Solter, D. 2005. Politically correct human embryonic stem
cells? N. Engl. J. Med. 353: 2321-2323.
12. Motosugi, N., Bauer, T., Polanski, Z., Solter, D., and
Hiiragi, T. 2005. Polarity of the mouse embryo is established at blastocyst and
is not prepatterned. Genes Dev. 19: 1081-1092.
13. Solter, D. 2006. From teratocarcinomas to embryonic stem
cells and beyond: a history of embryonic stem cell research. Nat. Rev. Genet.
7: 319-327.
14. Motosugi, N., Dietrich, J.-E., Polanski, Z., Solter, D.,
and Hiiragi, T. 2006. Space asymmetry directs preferential sperm entry in the
absence of polarity in the mouse oocyte. PloS Biology 4: e135.
15. Otahal P, Schell TD, Hutchinson SC, Knowles BB and
Tevethia SS. 2006. Early immunization induces persistent tumor-infiltrating
CD8+ T cells against an immunodominant epitope and promotes life-long control
of pancreatic tumor progression in SV40 T antigen transgenic mice. J Immunol,
177: 3089-3099.
16. Evsikov AV, Graber JH, Holbrook AE, Hampl A, Oh, B, Eppig
JJ, Solter D, Knowles BB. 2006. Cracking the egg: molecular dynamics and
evolutionary aspects of the mouse oocyte-to-embryo transition. Genes and
Development, 20: 2713 - 2727.
17. Peaston AE, Knowles BB Hutchison K. 2007. Genome constancy
and plasticity during the oocyte to embryo transition. Human Fertility
10:55-69.
18. The International Stem Cell Initiative Consortium. 2007.
Characteristics of human embryonic stem cell lines: Results from the
International Stem Cell Initiative, Nature Biotech. 25: 803-814.
19. Otahal, P. Knowles BB, Tevethia SS & Schell TD. 2007.
Anti-CD40 Conditioning Enhances the TCD8 Response to a Highly Tolerogenic
Epitope and Subsequent Immunotherapy of SV40 T Antigen-Induced Pancreatic
Tumors. J Immunol. 179: 6686-6695.
20. Naxerova
K, Bult CJ, Peaston A, Fancher K, Knowles BB, Kasif S, and Kohane IS. 2008.
Analysis of gene expression in a developmental context emphasizes distinct
biological leitmotifs in human cancers. Genome Biology 9: R108.
21. Knowles
B. 2009. Balancing work and life: a conversation with Barbara Knowles.
Interview by Majlinda Lako and Susan Daher. Stem Cells. 27(5): 989-90.
22.
Lopez-Terrada D, Cheung SW, Finegold MJ, Knowles BB. 2009.
Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 40(10): 1512-5.
23. Knowles B et al. 2009. Consensus guidance for banking and
supply of human embryonic stem cell lines for research purposes. Stem Cell Rev.
5(4): 301-14.
24. International
Stem Cell Initiative Consortium, Akopian V, Andrews PW, Beil S, Benvenisty N,
Brehm J, Christie M, Ford A, Fox V, Gokhale PJ, Healy L, Holm F, Hovatta O,
Knowles BB, Ludwig TE, McKay RD, Miyazaki T, Nakatsuji N, Oh SK, Pera MF,
Rossant J, Stacey GN, Suemori H. 2010. Comparison of defined culture systems
for feeder cell free propagation of human embryonic stem cells. In Vitro Cell
Dev Biol Anim. 46(3-4):247-58.
25. Theisen
JW, Lim CY, Kadonaga JT. 2010. Three Key Subregions Contribute to the Function
of the Downstream RNA Polymerase II Core Promoter. Mol Cell Biol. Mol Cell
Biol. 2010 Jul;30(14):3471-9.
26. Avery S,
Zafarana G, Gokhale PJ, Andrews PW. 2010. The role of SMAD4 in human embryonic
stem cell self-renewal and stem cell fate. Stem Cells. 2010 May;28(5):863-73.
27. Varlakhanova
N, deVries WN, Cotterman RF, Donahue LR, Murray S, Knowles BB & Knoepfler
P. 2010. myc maintains embryonic stem cell survival, self-renewal and
pluripotency. Differentiation. 2010 Jul;80(1):9-19.
28. Messerschmidt
DM, Kemler R. 2010. Nanog is required for primitive endoderm formation through
a non-cell autonomous mechanism. Dev Biol. 2010 Aug 1;344(1):129-137.